CGEN SEC Filings: 8-K, 10-Q, S-3 & 424B – Compugen

Financials

TYPE

HEADLINE

FILED AT

20-F

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Mar 2, 2026

20-F

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Mar 4, 2025

20-F

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Mar 5, 2024

20-F/A

Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]

Aug 23, 2023

20-F

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Feb 28, 2023

20-F/A

Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]

Feb 28, 2022

News

TYPE

HEADLINE

FILED AT

6-K

NEWCompugen Reports Third Quarter 2026 Results and Pipeline Updates

Nov 9, 2026

6-K

Compugen Ltd. Announces Results of 2026 Annual General Meeting of Shareholders

Sep 10, 2026

6-K

Compugen Ltd. Announces 2026 Annual General Meeting of Shareholders

Aug 3, 2026

6-K

Compugen Reports Second Quarter 2026 Financial Results and Pipeline Progress

Aug 3, 2026

6-K

Compugen Reports First Quarter 2026 Financial Results and Corporate Update

May 18, 2026

6-K

Compugen Reports Strong 2025 Results, Extends Cash Runway to 2029 via AstraZeneca Royalty Monetization

Mar 2, 2026

Prospectus

TYPE

HEADLINE

FILED AT

424B5

ATM | Offering amount: $50,000,000

Jan 31, 2023

424B5

8,333,334 Ordinary Shares

Mar 12, 2020

424B5

67,922,836

Mar 11, 2020

424B5

5,316,457 Ordinary Shares

Jun 18, 2018

424B5

$200,000,000 Ordinary Shares Debt Securities Rights Warrants Units

May 25, 2018

424B2

$200,000,000 Ordinary Shares Debt Securities Rights Warrants Units

Oct 14, 2016

Registrations

TYPE

HEADLINE

FILED AT

F-3

[No Baby Shelf]* May 2026 SHELF + ATM

May 18, 2026

F-3/A

SHELF EFFECTIVE

Jun 23, 2023

F-3/A

SHELF | ATM | Offering amount: $350,000,000.00 EFFECTIVE

Apr 14, 2023

F-3

SHELF | ATM | Offering amount: $350,000,000.00 EFFECTIVE

Mar 30, 2023

S-8

Registration

Aug 4, 2022

Form D - Notice of Exempt Offering of Securities - Item 06b

Nov 22, 2021

Proxies

TYPE

HEADLINE

FILED AT

Ownerships

TYPE

HEADLINE

FILED AT

Levine Zurit (Reporting)

Jul 30, 2026

Silberman David (Reporting)

Jul 30, 2026

Ophir Eran (Reporting)

Jul 30, 2026

Cohen-Dayag Anat (Reporting)

Jul 30, 2026

Perry Eran (Reporting)

Jul 30, 2026

Ferre Pierre (Reporting)

Jul 30, 2026

Other

TYPE

HEADLINE

FILED AT

LETTER

Form UPLOAD - SEC-generated letter

Aug 4, 2026

CORRESP

Form CORRESP - Correspondence

Jul 28, 2026

LETTER

Form UPLOAD - SEC-generated letter

Jul 17, 2026

EFFECT

Form EFFECT - Notice of Effectiveness

Jun 9, 2026

CORRESP

Form CORRESP - Correspondence

Jun 4, 2026

LETTER

Form UPLOAD - SEC-generated letter

May 21, 2026

Compugen Ltd. CGEN · SEC Filings